alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 1065 Introduced in Senate (IS)]

109th CONGRESS
  1st Session
                                S. 1065

To amend title 10, United States Code, to extend child care eligibility 
  for children of members of the Armed Forces who die in the line of 
                                 duty.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 18, 2005

   Mr. Thune (for himself and Mrs. Clinton) introduced the following 
   bill; which was read twice and referred to the Committee on Armed 
                                Services

_______________________________________________________________________

                                 A BILL

 
To amend title 10, United States Code, to extend child care eligibility 
  for children of members of the Armed Forces who die in the line of 
                                 duty.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. EXTENSION OF CHILD CARE ELIGIBILITY FOR CHILDREN OF MEMBERS 
              OF THE ARMED FORCES WHO DIE IN THE LINE OF DUTY.

    Section 1799 of title 10, United States Code, is amended by adding 
at the end the following:
    ``(d) Children Whose Military Parent Dies in Line of Duty.--If a 
member of the armed forces dies on active duty, or a member of a 
reserve component of the armed forces dies while in active service, any 
child of such member who is enrolled in a Federal child care program 
shall be eligible to continue receiving services under such program for 
a period of 24 months following such death.''.
                                 <all>
```
§ 1150.13 Payment of assessments. ( a ) Payment of an assessment must be received by FDA no later than the last day of each fiscal year quarter.
( b ) Payments must be submitted to FDA in U.S. dollars and in the manner specified in the notification.
( c ) Except as provided in paragraph (d) of this section, if an assessment is not received by the last day of the fiscal year quarter, FDA will begin assessing interest on the unpaid amount in accordance with 31 U.S.C. 3717.
( d ) If FDA does not send the notification described in § 1150.11(a) 30 calendar days before the end of a quarter, no interest will be assessed by FDA under paragraph (c) of this section until 30 calendar days have elapsed from the date FDA sent notification of the amount owed.
( e ) If a domestic manufacturer or importer disputes the amount of an assessment, it must still pay the assessment in accordance with paragraphs (a) and (b) of this section.
#### The People of the State of New York ex rel. Robert D. Hawkins, Appellant, v. J. Edwin La Vallee, as Warden of Clinton Prison, Respondent.

Appeal dismissed by consent, without costs, on the ground that relator has been released on parole (see *People ex rel. Wilder*v. *Marhley,*26 N Y 2d 648). Herlihy, P. J., Reynolds, Aulisi, Staley, Jr., and Greenblott, JJ., concur.
# m8606.docx

EUROPEAN COMMISSION Brussels,12.3.2018 C(2018) 1589 final To the Notifying Parties Subject : Case M. 8606 – ELG HANIEL / IBERINOX / JV Commission decision pursuant to Article 6(1 )( b) of Council Regulation (EC) No 139/2004 1 and Article 57 of the Agreement on the European Economic Area 2 Dear Sir or Madam, 1. On 16 February 2018 , the European Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of the Merger Regulation by which the undertakings ELG Haniel GmbH ( "ELG Haniel ", Germany ) and Iberinox 88 S.A. ( " Iberinox ", Spain ), acquire within the meaning of Article 3(1)(b) and Article 3(4) of the Merger Regulation joint control over Sorpesante , S.L, ( "the JV", Spain ) by way of purchase of shares . 3 2. The business activities of the undertakings concerned are: - for ELG Haniel : is active in the worldwide trade of raw materials for the steel industry; - for Iberinox : is also active in the trade of raw materials for the steel industry, with its core business focused on stainless steel scrap; - for the JV: will be active in the trade in raw materials for the steel industry. To this end, it will take over Iberinox ' business with the exception of the activities of its subsidiary Aleaciones e Inoxidables Acerec , S.A, which will continue its current business unaffected by the proposed concentration. 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5 ( c ) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 . 4 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1 )( b) of the Merger Regulation and Article 57 of the EEA Agreement . For the Commission ( Signed )
Johannes LAITENBERGER Director - General
(1)
OJ L 24, 29.1.2004, p. 1 ( the ' Merger Regulation ' ). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ( ' TFEU ' ) has introduced certain changes, such as the replacement of ' Community ' by ' Union ' and ' common market ' by ' internal market ' . The terminology of the TFEU will be used throughout this decision.
(2) OJ L 1, 3.1.1994, p. 3 ( the ' EEA Agreement ' ).
(3) Publication in the Official Journal of the European Union No C 069 , 23 . 2 . 2018 , p. 23 .
(4)
OJ C 366, 14.12.2013, p. 5 .
§ 1303.22 Procedure for applying for individual manufacturing quotas. Any person who is registered to manufacture any basic class of controlled substance listed in schedule I or II and who desires to manufacture a quantity of such class shall apply on DEA Form 189 for a manufacturing quota and shall state separately for each subcategory, as defined in § 1303.04, each quantity of such class. Copies of DEA Form 189 may be obtained from, and shall be filed (on or before May 1 of the year preceding the calendar year for which the manufacturing quota is being applied) with, the UN Reporting and Quota Section, Diversion Control Division. See the Table of DEA Mailing Addresses in § 1321.01 of this chapter for the current mailing address. A separate application must be made for each basic class desired to be manufactured. The applicant shall state: ( a ) The name and Administration Controlled Substances Code Number, as set forth in part 1308 of this chapter, of the basic class.
( b ) For the basic class in each of the current and preceding 2 calendar years, ( 1 ) The authorized individual manufacturing quota, if any;
( 2 ) The actual or estimated quantity manufactured;
( 3 ) The actual or estimated net disposal;
( 4 ) The actual or estimated inventory allowance pursuant to § 1303.24; and
( 5 ) The actual or estimated inventory as of December 31;
( c ) For the basic class in the next calendar year, ( 1 ) The desired individual manufacturing quota; and
( 2 ) Any additional factors which the applicant finds relevant to the fixing of his individual manufacturing quota, including the trend of (and recent changes in) his and the national rates of net disposal, his production cycle and current inventory position, the economic and physical availability of raw materials for use in manufacturing and for inventory purposes, yield and stability problems, potential disruptions to production (including possible labor strikes) and recent unforeseen emergencies such as floods and fires.
( d ) The Administrator may require additional information from an applicant which, in the Administrator's judgment, may be helpful in detecting or preventing diversion, including customer identities and amounts of the controlled substance sold to each customer.
[36 FR 7786, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971; 37 FR 15920, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 46 FR 28841, May 29, 1981; 51 FR 5319, Feb. 13, 1986; 62 FR 13958, Mar. 24, 1997; 75 FR 10677, Mar. 9, 2010; 81 FR 97020, Dec. 30, 2016; 83 FR 32790, July 16, 2018; 88 FR 60141, Aug. 31, 2023]
§ 625.2 Definitions. ( a ) *DOE.* DOE is the Department of Energy established by Public Law 95-91 (42 U.S.C. 7101 *et seq.*) and any component thereof including the SPR Office.
( b ) *Notice of Sale.* The Notice of Sale is the document announcing the sale of SPR petroleum, the amount, type and location of the petroleum being sold, the delivery period and the procedures for submitting offers. The Notice of Sale will specify which contractual provisions and financial and performance responsibility measures are applicable to that particular sale of petroleum, and will provide other pertinent information.
( c ) *Petroleum.* Petroleum means crude oil, residual fuel oil or any refined petroleum product (including any natural gas liquid and any natural gas liquid product) owned or contracted for by DOE and in storage in any permanent SPR facility, or temporarily stored in other storage facilities, or in transit to such facilities (including petroleum under contract but not yet delivered to a loading terminal).
( d ) *Price Competitive Sale.* A price competitive sale of SPR petroleum is one in which contract awards are made to those responsive, responsible persons offering the highest prices; sales conducted pursuant to rules adopted under section 161(e) of the Energy Policy and Conservation Act (EPCA), Public Law 94-163 (42 U.S.C. 6201 *et seq.*), are not price competitive sales.
( e ) *Purchaser.* A purchaser is any person or entity (including a Government agency) which enters into a contract with DOE to purchase SPR petroleum.
( f ) *SPR.* SPR is the Strategic Petroleum Reserve, that program of the Department of Energy established by title I, part B of EPCA.
( g ) *Standard Sales Provisions.* The Standard Sales Provisions are a set of terms and conditions of sale, which may contain or describe financial and performance responsibility measures, for petroleum sold from the SPR under this part.
*Product ingredient source information may be entitled to confidential treatment**Product ingredient source information may be entitled to confidential treatment**Product ingredient source information may be entitled to confidential treatment*________ Page is not included in this copy. Pages 184 through 188 are not included in this copy.

_________________________________________________________________ The material not included contains the following type of information: _____ Identity of product inert ingredients. _____ Identity of product impurities. Description of the product manufacturing process. _____ Description of quality control procedures. Identity of the source of product ingredients. _____ Sales or other commercial/financial information. _____ A draft product label.
X The product confidential statement of formula. _____ Information about a pending registration action. _____ FIFRA registration data. _____ The document is a duplicate of page(s) _______. _____ The document is not responsive to the request. Internal deliberative information. Attorney-client communication. Claimed confidential by submitter upon submission to the Agency. _____ Third party confidential business information.

_________________________________________________________________ The information not included is generally considered confidential by product r egistrants. If you have any questions, please contact the individual who prepared the response to your request.
§ 1401.305 What must I include in my drug-free workplace statement? You must publish a statement that— ( a ) Tells your employees that the unlawful manufacture, distribution, dispensing, possession, or use of a controlled substance is prohibited in your workplace;
( b ) Specifies the actions that you will take against employees for violating that prohibition; and
( c ) Lets each employee know that, as a condition of employment under any award, he or she: ( 1 ) Will abide by the terms of the statement; and
( 2 ) Must notify you in writing if he or she is convicted for a violation of a criminal drug statute occurring in the workplace and must do so no more than five calendar days after the conviction.
#### RICHARDS v. ROBIN et al.

(Supreme Court, Appellate Division, First Department.

July 10, 1914.)

Action by Eugene L. Richards as superintendent, etc., against Joseph C. Robin and others.

No opinion. Motion denied, with $10 costs. Order filed. See, also, 148 N. Y. Supp. 822.
§ 1.1108 When and how will FDA issue a directed food laboratory order? ( a ) FDA may require the owner or consignee to conduct food testing, or to have food testing conducted on their behalf, under this subpart to address an identified or suspected food safety problem, as FDA deems appropriate.
( b ) The directed food laboratory order will specify the food product or environment to be tested; whether the food testing may be conducted using a LAAF-accredited laboratory that is owned, operated, or controlled by the owner or consignee; the timeframe in which the food testing must be conducted; and the manner of the food testing, such as the methods that must be used.
( c ) The directed food laboratory order will contain all the elements required by § 16.22(a) of this chapter and will thereby constitute the notice of an opportunity for hearing under part 16 of this chapter. An affected owner or consignee may request a regulatory hearing on a directed food laboratory order pursuant to § 1.1174.
#### § 1400.881 May a respondent seek award eligibility reinstatement at any time before the end of the period of debarment?

In addition to a petition for reconsideration based on a clear error of material fact or law, a respondent may, at any time following imposition of debarment, request the Suspending and Debarring Official to reduce or terminate the period of debarment based upon the factors under the provisions of 2 CFR 180.880.
### THE THIRTEENTH COURT OF APPEALS

13

- 23

- 00135

- CV
3HM TRUCKING, LLC, MICHAEL JEROME WRIGHT, PRESTIGE GUNITE, INC., JESUS MARIA ROSALES, III, TRI

- NATIONAL, INC., AND RMR DRIVER SERVICES, INC. v. JOANN CARR ELIZONDO, ET AL.
On Appeal from the 92nd Distri ct Court of Hidalgo County , Texas Trial Court Cause No. C

- 4439

- 22

- A

JUDGMENT THE THIRTEENTH COURT OF APPEALS, having considered this cause on appeal, concludes that the judgment of the trial court should be affirmed . The Court orders the judgment of the trial court AFFIRMED . Costs of the appeal are adjudged against appellant s

. We further order this decision certified below for observance. March 21, 2024
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 894 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
H. RES. 894

    Seeking the return of the USS Pueblo to the United States Navy.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 15, 2018

 Mr. Tipton submitted the following resolution; which was referred to 
                    the Committee on Foreign Affairs

_______________________________________________________________________

                               RESOLUTION

 
    Seeking the return of the USS Pueblo to the United States Navy.

Whereas the USS Pueblo, which was attacked and captured by the Navy of North 
        Korea on January 23, 1968, was the first ship of the United States Navy 
        to be hijacked on the high seas by a foreign military force in more than 
        150 years;
Whereas 1 member of the USS Pueblo crew, Petty Officer Duane Hodges, was killed 
        in the assault, while the other 82 crew members were held in captivity, 
        often under inhumane conditions, for 11 months;
Whereas the USS Pueblo, an intelligence collection auxiliary vessel, was 
        operating in international waters at the time of the capture, and 
        therefore did not violate the territorial waters of North Korea;
Whereas the capture of the USS Pueblo resulted in no reprisals against the 
        Government or people of North Korea and no military action at any time; 
        and
Whereas the USS Pueblo, though still the property of the United States Navy, has 
        been retained by the Government of North Korea for more than 50 years, 
        was subjected to exhibition in the North Korean cities of Wonsan and 
        Hungham, and is now on display in Pyongyang, the capital city of North 
        Korea: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) desires the return of the USS Pueblo to the United 
        States Navy;
            (2) would welcome the return of the USS Pueblo as a sign of 
        good faith from the North Korean people to the American people; 
        and
            (3) directs the Clerk of the House of Representatives to 
        transmit copies of this resolution to the President, the 
        Secretary of Defense, and the Secretary of State.
                                 <all>
```
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 759 Engrossed in House (EH)]

<DOC>
H. Res. 759

                In the House of Representatives, U. S.,

                                                         March 1, 2018.
    Resolved, That the House of Representatives offers its deep sympathies to 
the members of the family of the late Reverend Billy Graham.
    Resolved, That the House of Representatives honors the legacy of Reverend 
Billy Graham for his life-long commitment to preaching the Gospels, his fight 
for civil rights, his opposition to communism, and the spiritual guidance that 
he provided to millions of people in the United States and around the world.
    Resolved, That when the House adjourns today, it do so as a mark of respect 
to the memory of the late Billy Graham.
            Attest:

                                                                          Clerk.
```
MEMORANDUM March 16, 2011 

SUBJECT: Meeting with the Illinois Corn Growers Association on Proposed Rules for E15

FROM: Jim Caldwell, Office of Transportation and Air Quality (OTAQ)

TO: Air and Radiation Docket (6102T), Docket ID No. EPA-HQ-OAR-2010-0448

Date of Meeting: March 15, 2011

Location: 1310 L Street, NW, Washington, DC 20005

Attendees:

Wayne Anderson – Illinois Corn Growers Association

David Beaudreau, Jr. – DC Legislative & Regulatory Services, Inc.

Jessica Bennett – National Corn Growers Association

Tim Lentz – Illinois Corn Growers Association

Dave Loos – Illinois Corn Growers Association

Jim Caldwell – EPA/OTAQ

Mary Manners – EPA/OTAQ

Deborah Wood – EPA/OTAQ

Mr. Loos was interested in the timing for the final rule. We said this spring. Mr. Loos 

stated that the E15 pump labels should be informational and not alarming, and marketers should 

have flexibility in the size and other aspects of the labels. Several E15 issues unrelated to the 

rulemaking were also discussed.
Editorial Note on Part 107
Editorial Note: Nomenclature changes to part 107 appear at 81 FR 49895, July 29, 2016.

§ 107.220 Scope and effect of infant formula recalls. ( a ) The requirements of this subpart apply: ( 1 ) When the Food and Drug Administration has determined that it is necessary to remove from the market a distributed infant formula that is in violation of the laws and regulations administered by the Food and Drug Administration and that poses a risk to human health; or
( 2 ) When a manufacturer has determined that it is necessary to remove from the market a distributed infant formula that: ( i ) Is no longer subject to the manufacturer's control;
( ii ) Is in violation of the laws and regulations administered by the Food and Drug Administration and against which the agency could initiate legal or regulatory action; and
( iii ) Does not present a human risk.
( b ) The Food and Drug Administration will monitor continually the recall action and will take appropriate actions to ensure that the violative infant formula is removed from the market.
§ 1.1101 What documents are incorporated by reference in this subpart ( a ) Certain material is incorporated by reference into this subpart with the approval of the Director of the Federal Register under 5 U.S.C. 552(a) and 1 CFR part 51. All approved material is available for inspection at the Food and Drug Administration's Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240-402-7500, and is available from the source listed elsewhere in this section. It is also available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, email *fr.inspection@nara.gov* or go to *https://www.archives.gov/federal-register/cfr/ibr-locations.html .*
( b ) International Organization for Standardization (ISO), Chemin de Blandonnet 8, CP 401, 1214 Vernier, Geneva, Switzerland; Telephone 41 22 749 01 11, *https://www.iso.org/home.html .* ( 1 ) ISO/IEC 17011:2017(E), Conformity assessment—Requirements for accreditation bodies accrediting conformity assessment bodies, Second edition, November 2017, IBR approved for §§ 1.1113(a) and (c), 1.1114(b), 1.1120(c), 1.1131(a).
( 2 ) ISO/IEC 17025:2017(E), General requirements for the competence of testing and calibration laboratories, Third edition, November 2017, IBR approved for §§ 1.1120(c), 1.1121(a), 1.1138(a), 1.1139(b) and (c), 1.1141(a), 1.1152(a) and (d), 1.1153(c), and 1.1161(a).
§ 1.1117 How may an accreditation body request reinstatement of recognition? ( a ) *Application following revocation of recognition.* An accreditation body that has had its recognition revoked by FDA (as described in § 1.1131) may seek reinstatement by submitting a new application for recognition under § 1.1114. The accreditation body must also submit evidence to FDA with its application to demonstrate that the issues resulting in revocation of recognition have been resolved, including evidence addressing the cause or condition of the grounds for revocation of recognition. The evidence also must identify measures that have been implemented to help ensure that such cause or condition is unlikely to recur.
( b ) *Application following relinquishment or expiration of recognition.* An accreditation body that previously relinquished its recognition or allowed its recognition to expire (as described in § 1.1116) may seek reinstatement by submitting a new application for recognition under § 1.1114.
#### § 5800.332 What methods must I use to pass requirements down to participants at lower tiers with whom I intend to do business?

If a lower-tier transaction is covered pursuant to § 5800.220, you as a participant must include a term or condition in lower-tier transactions requiring lower-tier participants to comply with Subpart C of the OMB guidance in 2 CFR part 180.